BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 23042304)

  • 1. Effect of CpG methylation at different sequence context on acrolein- and BPDE-DNA binding and mutagenesis.
    Wang HT; Weng MW; Chen WC; Yobin M; Pan J; Chung FL; Wu XR; Rom W; Tang MS
    Carcinogenesis; 2013 Jan; 34(1):220-7. PubMed ID: 23042304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylated CpG dinucleotides are the preferential targets for G-to-T transversion mutations induced by benzo[a]pyrene diol epoxide in mammalian cells: similarities with the p53 mutation spectrum in smoking-associated lung cancers.
    Yoon JH; Smith LE; Feng Z; Tang M; Lee CS; Pfeifer GP
    Cancer Res; 2001 Oct; 61(19):7110-7. PubMed ID: 11585742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acrolein is a major cigarette-related lung cancer agent: Preferential binding at p53 mutational hotspots and inhibition of DNA repair.
    Feng Z; Hu W; Hu Y; Tang MS
    Proc Natl Acad Sci U S A; 2006 Oct; 103(42):15404-9. PubMed ID: 17030796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of UvrABC nuclease to quantify benzo[a]pyrene diol epoxide-DNA adduct formation at methylated versus unmethylated CpG sites in the p53 gene.
    Tang MS; Zheng JB; Denissenko MF; Pfeifer GP; Zheng Y
    Carcinogenesis; 1999 Jun; 20(6):1085-9. PubMed ID: 10357792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutagenicity and sequence specificity of acrolein-DNA adducts.
    Wang HT; Zhang S; Hu Y; Tang MS
    Chem Res Toxicol; 2009 Mar; 22(3):511-7. PubMed ID: 19146376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of carcinogenic acrolein on DNA repair and mutagenic susceptibility.
    Wang HT; Hu Y; Tong D; Huang J; Gu L; Wu XR; Chung FL; Li GM; Tang MS
    J Biol Chem; 2012 Apr; 287(15):12379-86. PubMed ID: 22275365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53.
    Denissenko MF; Pao A; Tang M; Pfeifer GP
    Science; 1996 Oct; 274(5286):430-2. PubMed ID: 8832894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formation of benzo[a]pyrene diol epoxide-DNA adducts at specific guanines within K-ras and p53 gene sequences: stable isotope-labeling mass spectrometry approach.
    Tretyakova N; Matter B; Jones R; Shallop A
    Biochemistry; 2002 Jul; 41(30):9535-44. PubMed ID: 12135376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conformational changes of a benzo[a]pyrene diol epoxide-N(2)-dG adduct induced by a 5'-flanking 5-methyl-substituted cytosine in a (Me)CG double-stranded oligonucleotide sequence context.
    Huang X; Colgate KC; Kolbanovskiy A; Amin S; Geacintov NE
    Chem Res Toxicol; 2002 Mar; 15(3):438-44. PubMed ID: 11896693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TP53 mutations induced by BPDE in Xpa-WT and Xpa-Null human TP53 knock-in (Hupki) mouse embryo fibroblasts.
    Kucab JE; van Steeg H; Luijten M; Schmeiser HH; White PA; Phillips DH; Arlt VM
    Mutat Res; 2015 Mar; 773():48-62. PubMed ID: 25847421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutagenic potential of benzo[a]pyrene-derived DNA adducts positioned in codon 273 of the human P53 gene.
    Dong H; Bonala RR; Suzuki N; Johnson F; Grollman AP; Shibutani S
    Biochemistry; 2004 Dec; 43(50):15922-8. PubMed ID: 15595848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Slow repair of bulky DNA adducts along the nontranscribed strand of the human p53 gene may explain the strand bias of transversion mutations in cancers.
    Denissenko MF; Pao A; Pfeifer GP; Tang M
    Oncogene; 1998 Mar; 16(10):1241-7. PubMed ID: 9546425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of cytosine methylation on the chemoselectivity of benzo[a]pyrene diol epoxide-oligonucleotide adducts determined using nanoLC/MS/MS.
    Glick J; Xiong W; Lin Y; Noronha AM; Wilds CJ; Vouros P
    J Mass Spectrom; 2009 Aug; 44(8):1241-8. PubMed ID: 19536795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preferential carcinogen-DNA adduct formation at codons 12 and 14 in the human K-ras gene and their possible mechanisms.
    Hu W; Feng Z; Tang MS
    Biochemistry; 2003 Aug; 42(33):10012-23. PubMed ID: 12924950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arsenite enhances the benzo[a]pyrene diol epoxide (BPDE)-induced mutagenesis with no marked effect on repair of BPDE-DNA adducts in human lung cells.
    Chiang HC; Tsou TC
    Toxicol In Vitro; 2009 Aug; 23(5):897-905. PubMed ID: 19470404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cigarette side-stream smoke lung and bladder carcinogenesis: inducing mutagenic acrolein-DNA adducts, inhibiting DNA repair and enhancing anchorage-independent-growth cell transformation.
    Lee HW; Wang HT; Weng MW; Chin C; Huang W; Lepor H; Wu XR; Rom WN; Chen LC; Tang MS
    Oncotarget; 2015 Oct; 6(32):33226-36. PubMed ID: 26431382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presence of benzo[a]pyrene diol epoxide adducts in target DNA leads to an increase in UV-induced DNA single strand breaks and supF gene mutations.
    Routledge MN; McLuckie KI; Jones GD; Farmer PB; Martin EA
    Carcinogenesis; 2001 Aug; 22(8):1231-8. PubMed ID: 11470754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formation of diastereomeric benzo[a]pyrene diol epoxide-guanine adducts in p53 gene-derived DNA sequences.
    Matter B; Wang G; Jones R; Tretyakova N
    Chem Res Toxicol; 2004 Jun; 17(6):731-41. PubMed ID: 15206894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Site-specific rates of excision repair of benzo[a]pyrene diol epoxide adducts in the hypoxanthine phosphoribosyltransferase gene of human fibroblasts: correlation with mutation spectra.
    Wei D; Maher VM; McCormick JJ
    Proc Natl Acad Sci U S A; 1995 Mar; 92(6):2204-8. PubMed ID: 7892248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutability of p53 hotspot codons to benzo(a)pyrene diol epoxide (BPDE) and the frequency of p53 mutations in nontumorous human lung.
    Hussain SP; Amstad P; Raja K; Sawyer M; Hofseth L; Shields PG; Hewer A; Phillips DH; Ryberg D; Haugen A; Harris CC
    Cancer Res; 2001 Sep; 61(17):6350-5. PubMed ID: 11522624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.